Company intelligence / Profile preview

CoMind

London, England, United Kingdomcomind.io ↗

Ownership: Private
Employees: ~61
Development stage: Preclinical

Overview

CoMind has developed a non-invasive brain-monitoring device using light-based technology and AI analytics. Their platform provides real-time predictive insights to clinicians to improve patient safety and outcomes across various acute care settings. No drug or therapeutic clinical trial results are reported; the focus is on device performance and healthcare impact.

Therapeutic areas: Neurology
Modalities: DeviceSoftware (AI-powered platform for brain monitoring)
Industry: Physiological Monitoring

Beyond the preview

Go deeper on CoMind.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CoMind.

Explore the full profile